Amphastar Pharmaceuticals Inc (AMPH) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Amphastar Pharmaceuticals Inc   (NASDAQ: AMPH)


Amphastar Pharmaceuticals Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Amphastar Pharmaceuticals Inc's ROI in the third quarter of 2026?
Amphastar Pharmaceuticals Inc achieved a return on average invested assets (ROI) of 6.64 % in its third quarter of 2026, this is above AMPH's average return on investment of 5.57%.
Amphastar Pharmaceuticals Inc invested over the 12 months ending in its third quarter of 2026 $1,491 million

ROI has improved compared to 5.33% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 141 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 1435 to 1457.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 4.1 % 4.25 % 5.83 % 6.9 % 7.97 %
Y / Y Net Income Change TTM -11.35 % -41.69 % -23.58 % 25.13 % 176.11 %
Investment (TTM) in Millions 1,530 1,481 1,484 1,471 1,461
Return On Investment (TTM) 6.64 % 5.33 % 5.41 % 6.77 % 7.79 %
AMPH's Overall Ranking # 1457 # 1435 # 821 # 772 #
Seq. Investment Change TTM 1.18 % 0.71 % 0.97 % 1.18 % 1.32 %
Seq. Net Income Change TTM 25.99 % -0.86 % -19.23 % -12.12 % -17.13 %
Net Income (TTM) in Millions 99 79 79 98 112

AMPH Company Profile >> Back to AMPH Roi Comparisons >> See Annual AMPH Return On Investment



Return On Investment AMPH's Ranking
Within: No.
Industry # 51
Sector # 142
Overall # 1457

Return On Investment Statistics
High Average Low
15.73 %
5.57 %
-4.61 %
(Jun 30 2022)   (Jun 30 2015)







Financial Statements
Amphastar Pharmaceuticals Inc's III. Quarter Investments $ 1,530 Millions AMPH's Balance sheet
Amphastar Pharmaceuticals Inc's III. Quarter Income $ 38 Millions Quarterly AMPH's Income Statement
AMPH's Income by Division See AMPH's Income by Division


AMPH Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,471 1,404 1,288 647 568
Y / Y Investment Growth 4.8 % 9.03 % 98.96 % 13.99 % 0.4 %
Net Income in Millions 98 160 138 91 63
Y / Y Net Income Growth -38.51 % 15.98 % 50.51 % 44.37 % 5670.37 %
Annual Return On Investment 6.67 % 11.36 % 10.68 % 14.12 % 11.15 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 6.67 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AMPH's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AMPH's Competitors
Subscribers only: Roi for Amphastar Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for AMPH's Customers

Other Ratios
AMPH's Roa AMPH's Inventory Turnover Ratio AMPH's Growth Rates AMPH's Dividend Statistics
AMPH's Profitability Ratios AMPH's Asset Turnover Ratio AMPH's Dividend Growth
AMPH's Roe AMPH's Valuation Ratios AMPH's Financial Strength Ratios AMPH's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %
Boston Scientific Corporation  9.14 %
Brightspring Health Services Inc   9.01 %

Date modified: 2026-11-06T12:56:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.